Tag: NGS
Application Of Liquid Biopsy NGS In Non-Squamous Cell Lung Carcinoma Patient Treatment Decisions
Lung cancer is the leading cause of cancer related death. Squamous-cell
carcinoma, a type of non-small-cell lung carcinoma (NSCLC), comprises 25–30% of
all lung cancer cases and is strongly correlated with cigarette smoking. The
remaining 70-75% of lung cancer cases can be...
New Next Generation Sequencing Service With Lower Cost Than Genotyping Arrays, Ideal For Biobanks
BGI Americas and Gencove have entered into an agreement to offer a new low-pass sequencing service to lower barriers to large-scale genomics projects, such as carried out by the well-known national biobanks, and others. The service combines BGI’s DNBseq™...
Million Veteran Program Extends Personalis Sequencing Contracts To Almost 80,000 Human Genomes
Personalis, Inc., founded in 2011, based in Silicon Valley, a provider of advanced genomic sequencing and analytics for immuno-oncology, has announced an extension to their contract with the US Department of Veterans Affairs (VA) to sequence a further 34,000...
